CN103690844A

CN103690844A - External traditional Chinese medicine for treating urticaria

Info

Publication number: CN103690844A
Application number: CN201310612478.5A
Authority: CN
Inventors: 祝迈
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-11-28
Filing date: 2013-11-28
Publication date: 2014-04-02

Abstract

The invention relates to an external traditional Chinese medicine for treating urticaria. The external traditional Chinese medicine for treating urticaria is composed of the following components by weight: 25-35 parts of radix sophorae flavescentis, 25-35 parts of rhizoma smilacis glabrae, 25-35 parts of cotex dictamni, 15-25 parts of common cnidium fruit, 10-15 parts of Herba Schizonepetae, 5-8 parts of Chinese prickly ash, 10-18 parts of radix sileris, 15-20 parts of Tribulus terrestris and 15-20 parts of periostracum cicadae. The external medicine is a water decoction preparation. The various raw materials in the medicine provided by the invention mutually cooperate and complement with each other to achieve the effect of treating urticaria. Through clinical usage, the external traditional Chinese medicine is proved to have fast effectiveness, effective rate of 92% and no toxic or side effect on patients.

Description

A kind of external application Chinese medicine for the treatment of urticaria

Technical field

The present invention relates to treat the external application Chinese medicine of urticaria.

Background technology

Urticaria is commonly called as rubella wheal.Be because skin, the little vasodilation of mucosa and permeability increase a kind of localized edema reaction occurring, conventionally in 2～24 hours, disappear, but new erythra occurs repeatedly.The course of disease delay a few days is to the several months.Comparatively common clinically.The urticaria welt that symptom is skin in early days, pimple, erythema and pruritus are uncomfortable, can erythra can disappear at any time, have seriously often occurred thickening of skin, have affected normal life.The cause of disease of urticaria is very complicated, and approximately 3/4 patient can not find reason, particularly chronic urticaria.Common cause mainly contains: food and food additive; Inhalation (inhalatio); Infect; Medicine; Physical factor is as mechanical stimulus, cold and hot, daylight etc.; Sting; Nervous and Mental Factors and endocrine alteration; Inherited genetic factors etc.

Drug therapy generally be take oral medicine as main, as Loratadine clinically; Suppress mast cell degranulation, reduce the medicine of histamine release; Glucocorticoid; Immunosuppressant.

Said medicine is taken as prolonged and repeated, and people is known from experience and causes certain side effect.

Summary of the invention

Technical problem to be solved by this invention is to provide a kind of external application Chinese medicine for the treatment of urticaria, and human body is not had to toxic and side effects, and the urticaria that a variety of causes is caused all has significant curative effect.

The technical scheme that the present invention solves the problems of the technologies described above is:

Treat an external application Chinese medicine for urticaria, crude drug is comprised of the component of following mass fraction: Radix Sophorae Flavescentis 25-35 part, Rhizoma Smilacis Glabrae 25-35 part, favus skin 25-35 part, Fructus Cnidii 15-25 part, Herba Schizonepetae 10-15 part, Pericarpium Zanthoxyli 5-8 part, Radix Saposhnikoviae 10-18 part, Fructus Atriplicis Sibiricae 15-20 part, Periostracum Cicadae 15-20 part.

Further, the mass fraction of described crude drug is preferably: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of favus skins, 20 parts of Fructus Cnidiis, 12 parts of Herba Schizonepetae, 6 parts, Pericarpium Zanthoxyli, 15 parts of Radix Saposhnikoviaes, 18 parts of Fructus Atriplicis Sibiricaees, 15 parts of Periostracum Cicadaes.

Further, this medicine for external use is water decoction.

In each component of the present invention, Radix Sophorae Flavescentis heat clearing and damp drying, parasite killing, diuresis.Rhizoma Smilacis Glabrae is sweet flat, dampness removing heat, removing toxic substances.Favus skin heat clearing and damp drying, the removing toxic substances of dispeling the wind.Fructus Cnidii dampness, dispels the wind, parasite killing.Herba Schizonepetae temperature, acrid in the mouth is bitter, dispels the wind, removing heat from blood.Pricklyash peel insecticidal itching relieving.Radix Saposhnikoviae expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic.Fructus Atriplicis Sibiricae can be controlled skin pruritus.The Periostracum Cicadae wind heat of faling apart.The various raw materials of the present invention cooperatively interact, and complement each other, and jointly reach the effect for the treatment of urticaria.Through clinical use, effect is fast, effective percentage reaches 92%, without any side effects to patient.

The specific embodiment

Below in conjunction with embodiment, the present invention will be described in detail.

Embodiment 1

Treat an external application Chinese medicine for urticaria, raw material is comprised of the component of following mass fraction: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of favus skins, 20 parts of Fructus Cnidiis, 12 parts of Herba Schizonepetae, 6 parts, Pericarpium Zanthoxyli, 15 parts of Radix Saposhnikoviaes, 18 parts of Fructus Atriplicis Sibiricaees, 15 parts of Periostracum Cicadaes.

Above-mentioned raw materials is decocted according to a conventional method as water decoction, first smokes while hot affected part, treats warm after washing, and every day sooner or later respectively once.

Experimental example

Select 50 routine urticaria patients to use external application Chinese medicine of the present invention, men and women does not limit, the age do not limit.Inclusion criteria is: outbreak repeatedly, and skin lesion differs in size, the edema speckle that shape differs, boundary line is clear; While rising during erythra, disappear, single skin lesion disappears and is no more than 24h, violent pruritus, and skin lesion appearing without definite location, leaves no trace after disappearing, and erythra is shown effect repeatedly, through 3 months, does not heal above; Cutaneous scarification is positive.

Use the crude drug of embodiment 1, decocting, first smokes affected part while hot according to a conventional method, treats warm after washing, every day, sooner or later respectively once tracing observation, added up after one month, found in 50 routine patients, 12 examples are cured, and effectively, 4 examples do not have clear improvement 34 examples, and effective percentage reaches 92%.

The standard of statistics is:

Cure---welt disappears, and clinical sign disappears, and does not reaccess;

Effectively---welt disappears 30%, or after disappearing, recurrence time extends, and the symptoms such as pruritus alleviate;

Invalid: welt and pruritus are not improved, or the less than 30% that disappears.

Claims

1. treat an external application Chinese medicine for urticaria, crude drug is comprised of the component of following mass fraction: Radix Sophorae Flavescentis 25-35 part, Rhizoma Smilacis Glabrae 25-35 part, favus skin 25-35 part, Fructus Cnidii 15-25 part, Herba Schizonepetae 10-15 part, Pericarpium Zanthoxyli 5-8 part, Radix Saposhnikoviae 10-18 part, Fructus Atriplicis Sibiricae 15-20 part, Periostracum Cicadae 15-20 part.

2. the external application Chinese medicine for the treatment of infantile eczema according to claim 1, is characterized in that the mass fraction of described crude drug is preferably: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Rhizoma Smilacis Glabraes, 30 parts of favus skins, 20 parts of Fructus Cnidiis, 12 parts of Herba Schizonepetae, 6 parts, Pericarpium Zanthoxyli, 15 parts of Radix Saposhnikoviaes, 18 parts of Fructus Atriplicis Sibiricaees, 15 parts of Periostracum Cicadaes.

3. the external application Chinese medicine for the treatment of infantile eczema according to claim 1, is characterized in that: this medicine for external use is water decoction.